Adjuvant Tegafur-Uracil Improves Survival in Low-Risk, Mismatch Repair Proficient Stage IIA Colon Cancer: A Propensity Score-Matched Analysis

<b>Background</b>: The benefit of adjuvant chemotherapy for low-risk, mismatch repair proficient (pMMR) stage IIA colon cancer is uncertain. Surveillance is standard, but some patients relapse. Tegafur-uracil (UFT) is a low-toxicity oral option that may offer benefit; <b>Methods</b>: This retrospect...

Description complète

Détails bibliographiques

Auteurs principaux:	Min-Chi Cheng, Hsu-Lin Lee, Shiue-Wei Lai, Jia-Hong Chen, Po-Huang Chen
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2025-12-01
Collection:	Life
Sujets:	colon cancer tegafur-uracil (UFT) adjuvant chemotherapy mismatch repair proficient (pMMR) propensity score matching
Accès en ligne:	https://www.mdpi.com/2075-1729/15/12/1930
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!